Rationale Cannabidiol (CBD) products lacking regulatory approval are being used to self-
treat a myriad of conditions and for their unsubstantiated health benefits. The scientific …

Objective: Two primary compounds of the cannabis plant (Cannabis sativa), delta-9-
tetrahydrocannabinol (THC) and cannabidiol (CBD), differentially and dose-dependently …

Background Although studied in a few randomized controlled trials, the efficacy of medical
cannabis (MC) for chronic pain remains controversial. Using an alternative approach, this …

Cannabis can synthetize more than 400 compounds, including terpenes, flavonoids, and
more than 100 phytocannabinoids. The main phytocannabinoids are Δ-9 …

Cannabis has been used for hundreds of years, with its ability to dampen feelings of anxiety
often reported as a primary reason for use. Only recently has the specific role cannabinoids …

Recent advances in cannabidiol (CBD) use in canines and felines for anxiety management,
pain management, and anti-inflammatory effects were reviewed using a literature search …

In recent years, several jurisdictions have revised their regulation policy toward both medical
and recreational use of cannabis. These changes have elicited concerns regarding how …

BackgroundRecent evidence suggests that cannabidiol (CBD), a non-intoxicating ingredient
present in cannabis extract, has an antipsychotic effect in people with established psychosis …

Background Cannabidiol (CBD) is a primary component in the cannabis plant; however, in
recent years, interest in CBD treatments has outpaced scientific research and regulatory …

Background: Cannabis is known to have a broad range of effects on behavior, including
experiencing a “high” and tranquility/relaxation. However, there are several adverse …